FDA Inspection 1010011 — Innovative Blood Resources, A Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, A Division Of New York Blood Center, Inc. on May 3, 2017 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln, NE (United States)